REQUEST A DEMO
Total
USD $0.00
Search more companies

Revismed Medical SRL (Romania)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Revismed Medical SRL Profile Updated: August 22, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Revismed Medical SRL is a company in Romania, with a head office in CLUJ-NAPOCA. The enterprise currently operates in the Medical Equipment and Supplies Manufacturing sector. The company was established on December 21, 2018. It currently has a total number of 9 (2022) employees. The latest financial highlights indicate a net sales revenue drop of 6.81% in 2022. There was a total growth of 41.92% in Revismed Medical SRL’s total assets over the same period. The enterprise’s net profit margin increased by 5.83% in 2022.

Headquarters
Strada Traian Vuia Nr. 92
CLUJ-NAPOCA; Cluj; Postal Code: 400387

Contact Details: Purchase the Revismed Medical SRL report to view the information.

Basic Information
Total Employees:
Purchase the Revismed Medical SRL report to view the information.
Outstanding Shares:
Purchase the Revismed Medical SRL report to view the information.
Registered Capital:
Purchase the Revismed Medical SRL report to view the information.
Incorporation Date:
December 21, 2018
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Revismed Medical SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-6.81%
Total operating revenue
-7.21%
Operating profit (EBIT)
39.76%
EBITDA
35.52%
Net Profit (Loss) for the Period
41.93%
Total assets
41.92%
Total equity
-59.74%
Operating Profit Margin (ROS)
7.48%
Net Profit Margin
5.83%
Return on Equity (ROE)
55.49%
Quick Ratio
-0.27%
Cash Ratio
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?